Here is the summary: 1. **Business Performance:** Aarti Industries reported 17% volume growth in FY25, led by exports, yet revenue was flat at ~₹8050 Cr.

EBITDA was muted by margin pressures.

Agrochemicals faced headwinds, while pharma/dyes segments remained stable.

2. **Growth Drivers or Strategy:** Aggressive cost optimization (targeting ₹300-450 Cr EBITDA boost) is pursued via efficiency projects and hybrid power.

Volume and margin ramp-ups in key products (Acid, Ethylation, MMA) aim to add ₹350-500 Cr.

Long-term, expanding into new markets like battery materials is strategic.

3. **Recent Developments:** AIL commissioned Ethylation (30 kT), Nitro-toluene (45 kT) expansions, and completed MMA capacity to 260 kT (from Q1 FY26). New JVs for plastic recycling (Re Aarti) and specialty chemicals (Augene Chemical) target CY26 commissioning.

4. **Key Financial Metrics:** Working capital days improved from ~85 to ~60. 5. **Management Commentary / Outlook:** Management anticipates consistent volume growth and a ₹1000 Cr capex for FY26. They project FY28 EBITDA of ₹1800-2200 Cr, targeting Debt/EBITDA 15%.